Optimal Conspicuity of Pancreatic Ductal Adenocarcinoma in Virtual Monochromatic Imaging Reconstructions on a Photon-counting Detector CT: Comparison to Conventional MDCT
Overview
Radiology
Authors
Affiliations
Purpose: To analyze the conspicuity of pancreatic ductal adenocarcinoma (PDAC) in virtual monoenergetic images (VMI) on a novel photon-counting detector CT (PCD-CT) in comparison to energy-integrating CT (EID-CT).
Methods: Inclusion criteria comprised initial diagnosis of PDAC (reference standard: histopathological analysis) and standardized contrast-enhanced CT imaging either on an EID-CT or a PCD-CT. Patients were excluded due to different histopathological diagnosis or missing tumor delineation on CT. On the PCD-CT, 40-190 keV VMI reconstructions were generated. Image noise, tumor-to-pancreas ratio (TPR) and contrast-to-noise ratio (CNR) were analyzed by ROI-based measurements in arterial and portal venous contrast phase. Two board-certified radiologist evaluated image quality and tumor delineation at both, EID-CT and PCD-CT (40 and 70 keV).
Results: Thirty-eight patients (mean age 70.4 years ± 10.3 [range 45-91], 27 males; PCD-CT: n=19, EID-CT: n=19) were retrospectively included. On the PCD-CT, tumor conspicuity (reflected by low TPR and high CNR) was significantly improved at low-energy VMI series (≤ 70 keV compared to > 70 keV), both in arterial and in portal venous contrast phase (P < 0.001), reaching the maximum at 40 keV. Comparison between PCD-CT and EID-CT showed significantly higher CNR on the PCD-CT in portal venous contrast phase at < 70 keV (P < 0.016). On the PCD-CT, tumor conspicuity was improved in portal venous contrast phase compared to arterial contrast phase especially at the lower end of the VMI spectrum (≤ 70 keV). Qualitative analysis revealed that tumor delineation is improved in 40 keV reconstructions compared to 70 keV reconstructions on a PCD-CT.
Conclusion: PCD-CT VMI reconstructions (≤ 70 keV) showed significantly improved conspicuity of PDAC in quantitative and qualitative analysis in both, arterial and portal venous contrast phase, compared to EID-CT, which may be important for early detection of tumor tissue in clinical routine. Tumor delineation was superior in portal venous contrast phase compared to arterial contrast phase.
Sharifi A, ODonnell T, Dane B Abdom Radiol (NY). 2025; .
PMID: 39934396 DOI: 10.1007/s00261-025-04832-z.
Ruff A, Li X, Goldberg J, Ehrhart M, Ginocchio L, Smereka P Abdom Radiol (NY). 2025; .
PMID: 39775026 DOI: 10.1007/s00261-024-04696-9.
Corallo C, Al-Adhami A, Jamieson N, Valle J, Radhakrishna G, Moir J Br J Radiol. 2024; 98(1165):13-26.
PMID: 39460945 PMC: 11652714. DOI: 10.1093/bjr/tqae217.
Liu P, Zhou S, Dong H, Li J, Xu Z, Lin S Jpn J Radiol. 2024; 43(2):309-318.
PMID: 39382795 DOI: 10.1007/s11604-024-01671-8.
Photon-counting CT: technical features and clinical impact on abdominal imaging.
Onishi H, Tsuboyama T, Nakamoto A, Ota T, Fukui H, Tatsumi M Abdom Radiol (NY). 2024; 49(12):4383-4399.
PMID: 38888738 PMC: 11522066. DOI: 10.1007/s00261-024-04414-5.